Skip to main content

NICE TAs

10/06/2020
TA628: Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer
10/06/2020
TA624: Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis
29/05/2020
TA379: Nintedanib for treating idiopathic pulmonary fibrosis
29/05/2020
TA620: Olaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer
29/05/2020
TA356: Ruxolitinib for treating polycythaemia vera (terminated appraisal)
29/05/2020
TA358: Tolvaptan for treating autosomal dominant polycystic kidney disease
22/05/2020
TA395: Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer
22/05/2020
TA355: Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
22/05/2020
TA354: Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism
18/05/2020
TA380: Panobinostat for treating multiple myeloma after at least 2 previous treatments
18/05/2020
TA366: Pembrolizumab for advanced melanoma not previously treated with ipilimumab
18/05/2020
TA393: Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
18/05/2020
TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa
18/05/2020
TA384: Nivolumab for treating advanced (unresectable or metastatic) melanoma
18/05/2020
TA483: Nivolumab for previously treated squamous non-small-cell lung cancer
18/05/2020
TA399: Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts
18/05/2020
TA388: Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction
18/05/2020
TA396: Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma
15/05/2020
TA414: Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma
13/05/2020
TA410: Talimogene laherparepvec for treating unresectable metastatic melanoma
Follow AWTTC: